Results 201 to 210 of about 340,092 (249)
Metformin for endometrial hyperplasia [PDF]
Cochrane Database of Systematic ReviewsEndometrial cancer is one of the most common gynaecological cancers in the world. Rates of endometrial cancer are rising, in part because of rising obesity rates. Endometrial hyperplasia is a precancerous condition in women that can lead to endometrial cancer if left untreated.
Hunain, Shiwani +3 more
openaire +3 more sources
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Uptake and Outcomes of Sentinel Lymph Node Mapping in Women With Atypical Endometrial Hyperplasia
Obstetrics and Gynecology, 2021Performance of sentinel lymph node mapping is increasing rapidly for women with complex atypical endometrial hyperplasia and is not associated with increased perioperative morbidity or mortality. OBJECTIVE: To examine the utilization, morbidity, and cost
S. Dioun +10 more
semanticscholar +1 more source
Seminars in Diagnostic Pathology, 2010
Endometrial hyperplasia is a heterogeneous set of pathologic lesions that range from mild, reversible glandular proliferations to direct cancer precursors. These lesions comprise a continuum of morphologic appearances, with the earliest proliferation represented by crowded glands with simple tubular architecture lined by cells resembling proliferative ...
Anne M, Mills, Teri A, Longacre
openaire +2 more sources
Endometrial hyperplasia is a heterogeneous set of pathologic lesions that range from mild, reversible glandular proliferations to direct cancer precursors. These lesions comprise a continuum of morphologic appearances, with the earliest proliferation represented by crowded glands with simple tubular architecture lined by cells resembling proliferative ...
Anne M, Mills, Teri A, Longacre
openaire +2 more sources
50 Studies Every Obstetrician-Gynecologist Should Know, 2021
This article provides a summary of a landmark study regarding the diagnosis of endometrial cancer. How accurate is endometrial sampling in women with endometrial carcinoma and hyperplasia?
C. Chandler, A. Olawaiye
semanticscholar +1 more source
This article provides a summary of a landmark study regarding the diagnosis of endometrial cancer. How accurate is endometrial sampling in women with endometrial carcinoma and hyperplasia?
C. Chandler, A. Olawaiye
semanticscholar +1 more source
The Obstetrician & Gynaecologist, 2008
The most common presenting symptom of endometrial hyperplasia is abnormal uterine bleeding. In the UK, hysteroscopy remains the gold standard of investigations for abnormal uterine bleeding. The clinical importance of endometrial hyperplasia largely relates to the risk of progression to endometrial carcinoma. Progestin therapy is appropriate for most
Julia E Palmer +2 more
openaire +1 more source
The most common presenting symptom of endometrial hyperplasia is abnormal uterine bleeding. In the UK, hysteroscopy remains the gold standard of investigations for abnormal uterine bleeding. The clinical importance of endometrial hyperplasia largely relates to the risk of progression to endometrial carcinoma. Progestin therapy is appropriate for most
Julia E Palmer +2 more
openaire +1 more source
Endometrial hyperplasia and the risk of coexistent cancer: WHO versus EIN criteria
Histopathology, 2019Endometrial hyperplasia (EH) is classified into benign and precancerous according to two different histomorphological systems: the World Health Organisation (WHO) system (based on the subjective evaluation of cytological atypia) and the endometrial ...
Antonio Travaglino +6 more
semanticscholar +1 more source
Gynecological Endocrinology, 2019
Objective: The conservative treatment of endometrial hyperplasia without atypia (HWA), atypical endometrial hyperplasia (AH/EIN) and early endometrioid carcinoma (EEC) is based on progestins.
A. Raffone +9 more
semanticscholar +1 more source
Objective: The conservative treatment of endometrial hyperplasia without atypia (HWA), atypical endometrial hyperplasia (AH/EIN) and early endometrioid carcinoma (EEC) is based on progestins.
A. Raffone +9 more
semanticscholar +1 more source
Nuclear expression of β‐catenin in endometrial hyperplasia as marker of premalignancy
Acta Pathologica, Microbiologica et Immunologica Scandinavica (APMIS), 2019We aimed to assess (1)‐whether nuclear β‐catenin is a marker of endometrial precancer, and (2)‐the diagnostic accuracy of β‐catenin immunohistochemistry in the differential diagnosis between benign and premalignant endometrial hyperplasia (EH), defining ...
Antonio Travaglino +8 more
semanticscholar +1 more source
Acta Pathologica, Microbiologica et Immunologica Scandinavica (APMIS), 2019
Guidelines recommend protein phosphatase and tensin homolog (PTEN) immunohistochemistry for differentiating between benign endometrial hyperplasia (BEH) and atypical endometrial hyperplasia/endometrioid intraepithelial neoplasia (AEH/EIN). However, it is
Antonio Travaglino +8 more
semanticscholar +1 more source
Guidelines recommend protein phosphatase and tensin homolog (PTEN) immunohistochemistry for differentiating between benign endometrial hyperplasia (BEH) and atypical endometrial hyperplasia/endometrioid intraepithelial neoplasia (AEH/EIN). However, it is
Antonio Travaglino +8 more
semanticscholar +1 more source
American Journal of Clinical Pathology, 2019
OBJECTIVES To assess congruence between World Health Organization (WHO) 1994 and endometrial intraepithelial neoplasia (EIN) classification systems of endometrial hyperplasia.
Antonio Travaglino +7 more
semanticscholar +1 more source
OBJECTIVES To assess congruence between World Health Organization (WHO) 1994 and endometrial intraepithelial neoplasia (EIN) classification systems of endometrial hyperplasia.
Antonio Travaglino +7 more
semanticscholar +1 more source